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Abstract: Different genomic alterations affecting the TCF4 gene are usually associated with Pitt-Hopkins syndrome 
(PTHS). This syndrome is a rare neurodevelopmental genetic disorder characterized by distinctive facial features, 
abnormal breathing, psychomotor delay and severe intellectual disability (ID). The genomic alterations include whole or 
partial gene deletion; balanced translocation disrupting the coding sequence of the gene; and intragenic variants. The 
TCF4 gene encodes a basic helix-loop-helix (bHLH) transcription factor 4. Using alternative promoters, TCF4 can be 
transcribed from a number of alternative initial exons, allowing for translation of variable protein isoforms containing 
different functional domains. Full-length TCF4 has two activation domains (AD1 and AD2) that are thought to modulate 
transcriptional activity, a NLS domain (nuclear localization signal) that controls subcellular localization and bHLH 
domain. Typical PTHS patients have aberration localized between exons 9 and 18 of the gene. On the other hand, variants 
affecting the first protein coding exons give rise to mild non-syndromic ID. We present a ten-year-old girl with 
psychomotor delay and mild ID without the typical features of PTHS. Genetic investigation using array-based 
comparative genomic hybridization, revealed a 73.45 kb deletion within the TCF4 gene. The deletion encompassing only 
exon 6 (NM_001083962). This deletion was not detected in both parents. Cytogenetic analysis excluded balanced 
translocation disrupting the coding sequence of the gene. To the best of our knowledge, this is the first case described in 
literature involving only exon 6. The findings in our patients support the notion that position of the alteration in TCF4 is 
relevant to the phenotype. Reporting our case we want to contribute to the phenotype-genotype correlation in patients 
with intragenomic deletion of TCF4 gene. 
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CASE REPORT 
Different genomic alterations affecting the TCF4 gene 
are usually associated with Pitt-Hopkins syndrome 
(PTHS). This syndrome is a rare autosomal dominant 
neurodevelopmental genetic disorder characterized by 
distinctive facial features, breathing abnormalities 
(hyperventilation episodes, apnea), ophthalmological 
disorders (strabismus, myopia), constipation, 
stereotypic movements, aggression, seizures, 
psychomotor delay and severe intellectual disability 
(ID).1, 2 The genomic aberrations include whole or 
partial gene deletion, balanced translocation disrupting 
the coding sequence of the gene, and intragenic variants 
(frameshift, splice-site, nonsense or missense mutation, 
most localized between exons 7 to 19).3, 4  In all PTHS 
patients with a heterozygous mutation in the TCF4 gene 
whose parents were available for analysis, the mutation 
was shown to occur de novo supporting an autosomal 
dominant inheritance pattern secondary to 
haploinsufficiency of TCF4.5 
The TCF4 gene (OMIM *602272) is located on 
chromosome 18q21.1 and encodes a basic helix-loop-
helix (bHLH) transcription factor 4. It can be transcribed 
using 21 mutually exclusive 5' initial exons (situated at 
various positions throughout exons 1-9), followed by 
constitutive internal exons 10-20,  and 3' exon 21 
(Figure 1). Full-length TCF4 has two activation domains 
(AD1 and AD2) that are thought to modulate 
transcriptional activity, a nuclear localization signal 
domain (NLS) that controls subcellular localization and 
a bHLH domain. The TCF4 gene is highly expressed in 
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Figure 1: Screenshot from UCSC Genome Browser of TCF4 genomic region (GRCh37/hg19). Exon numbering is referred to transcript 
NM_001083962. The blue shaded area indicates the deleted genomic region in presented case. The exons of the gene and predicted effect of variants 
affecting specific TCF4 gene regions according to our patient and previously reported cases is shown at the bottom of the figure. 
 
 
the developing and mature nervous system and  interacts 
with other bHLH transcription factors important in 
nervous system development. Using alternative 
promoters, the TCF4 gene can be transcribed from a 
number of alternative initial exons, allowing for the 
translation of variable protein isoforms containing 
different functional domains. Typical PTHS patients 
have an aberration localized between exons 9 and 18 of 
the gene. On the other hand, variants affecting the first 
protein-coding exons give rise to mild non-syndromic 
ID.5 
We present unique partial deletion encompassing only 
exon 6 of the TCF4 gene identified by chromosomal 
microarray in a ten-year-old girl with strabismus, 
myopia, adiposity, developmental delay and mild ID 
without  the  typical  features  of  PTHS.  Chromosomal 
microarray was carried out using Agilent SurePrint G3 
Unrestricted CGH ISCA v2 Human Genome 8x60 kit 
(Agilent Technologies, Santa Clara, CA, USA). Results 
were analysed using Agilent CytoGenomics (v4.0) 
software. Genetic testing revealed a de novo 73.45 kb 
heterozygous deletion in chromosomal region 18q21.1 
spanning from 53,050,621 bp to 53,124,075 bp 
(GRCh37/hg19) within the TCF4 gene. The deletion 
encompassed only exon 6 (numbering referred to 
transcript variant 1, NM_001083962) (Figure 1). The 
deletion was not detected in parents, and high resolution 
conventional cytogenetic analysis excluded balanced 
translocation disrupting the coding sequence of the 
gene. 
The finding in our patient verifies the annotation that the 
position of the alteration in TCF4 is relevant to the 
phenotype. Most of the reported intragenomic deletions 
of the TCF4 gene associated with PTHS include exons 
9 to 18. Only several cases have been described with 
partial deletion of the TCF4 gene affecting the first 
protein-coding exons.2 Clinical presentation of these 
patients includes minor dysmorphic features, speech 
delay, mild to moderate ID, ophthalmologic anomalies 
and is not in the clinical score of PTHS.  
 
 
Table 1. Genotype-phenotype correlation of published cases with deletion variants within the first eight exons of the TFC4 gene 
Patient P29 6 P1 6 P4 2 P14 2 P19 2 P15 2 Present report 
Deletion (exons) 4-6 4-6 4-5 4-8 4-8 5-6 6 
Age at evaluation 3y 5m 55y 5y 4m 3y 3m 6y 5m 2y 11m 10y 2m 
Intellectual disability moderate to severe? - n.a. n.a. n.a. n.a. mild 
Speech impairment absent - babble 6m babble 20m - babble 11m + 
Microcephaly - - n.a. n.a. n.a. n.a. - 
Motor incoordination n.a. - + + n.a. n.a. + 
Breathing anomalies - - - - + - - 
Constipation n.a. - - + + + + 













Typical facial features +/- - n.a. n.a. n.a. n.a. - 
Legend: The exons numbering refers to transcript variant 1, NM_001083962; n.a. - not available 
 
Morozin Pohovski L 
doi.org/ 10.33602/mebm.3.2.8 
Molecular and Experimental Biology in Medicine, 2020, 3(2): 56-58 
 
Our case further supports evidence that phenotype is 
largely dependent on the location of the alterations in the 
TCF4 gene, with milder phenotypes caused by deletion 
affecting less important functional domains of the 
protein. 3, 6, 7 To the best of our knowledge, this is the 
first case described in the literature involving only exon 
6 of the TCF4 gene in a patient without features of 
PTHS. This case contributes to the genotype-phenotype 
correlation by which loss-of-function variants within 
exons 4-6 give rise to a phenotype with mild ID without 
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